2.88
Schlusskurs vom Vortag:
$2.66
Offen:
$2.55
24-Stunden-Volumen:
419.69K
Relative Volume:
0.18
Marktkapitalisierung:
$11.97M
Einnahmen:
$9.37M
Nettoeinkommen (Verlust:
$-8.45M
KGV:
-3.5556
EPS:
-0.81
Netto-Cashflow:
$-7.27M
1W Leistung:
+17.55%
1M Leistung:
-64.44%
6M Leistung:
-80.80%
1J Leistung:
-94.87%
Bioaffinity Technologies Inc Stock (BIAF) Company Profile
Firmenname
Bioaffinity Technologies Inc
Sektor
Branche
Telefon
210-698-5334
Adresse
3300 NACOGDOCHES ROAD, SAN ANTONIO
Vergleichen Sie BIAF mit anderen Aktien
Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
---|---|---|---|---|---|---|
![]()
BIAF
Bioaffinity Technologies Inc
|
2.88 | 11.97M | 9.37M | -8.45M | -7.27M | -0.81 |
![]()
TMO
Thermo Fisher Scientific Inc
|
525.83 | 198.09B | 43.21B | 6.58B | 6.17B | 17.28 |
![]()
DHR
Danaher Corp
|
206.15 | 146.89B | 24.01B | 3.41B | 4.86B | 4.7082 |
![]()
IDXX
Idexx Laboratories Inc
|
636.91 | 50.67B | 4.04B | 985.66M | 774.34M | 12.01 |
![]()
A
Agilent Technologies Inc
|
138.04 | 39.19B | 6.79B | 1.22B | 1.09B | 4.2644 |
![]()
IQV
Iqvia Holdings Inc
|
204.76 | 34.64B | 15.70B | 1.24B | 2.01B | 6.9036 |
Bioaffinity Technologies Inc Aktie (BIAF) Neueste Nachrichten
How institutional buying supports bioAffinity Technologies Inc. Equity Warrant stockWeekly Loss Report & Safe Capital Growth Tips - newser.com
Can trapped investors hope for a rebound in bioAffinity Technologies Inc. Equity WarrantMarket Sentiment Summary & Safe Entry Zone Tips - newser.com
Can trapped investors hope for a rebound in bioAffinity Technologies Inc.CPI Data & Daily Profit Maximizing Tips - newser.com
Forecasting bioAffinity Technologies Inc. Equity Warrant price range with options data2025 Momentum Check & Consistent Profit Trading Strategies - newser.com
Will bioAffinity Technologies Inc. Equity Warrant benefit from macro trendsForecast Cut & High Accuracy Trade Alerts - newser.com
Detecting price anomalies in bioAffinity Technologies Inc. Equity Warrant with AI2025 Institutional Moves & Daily Stock Momentum Reports - newser.com
Is bioAffinity Technologies Inc. Equity Warrant stock a good choice for value investorsQuarterly Portfolio Report & Low Volatility Stock Recommendations - newser.com
How to interpret RSI for bioAffinity Technologies Inc. stock2025 Trading Recap & Free Daily Entry Point Trade Alerts - newser.com
Will bioAffinity Technologies Inc. Equity Warrant stock beat EPS estimatesMarket Activity Summary & Weekly High Return Stock Forecasts - newser.com
Will bioAffinity Technologies Inc. stock deliver better than expected guidanceWeekly Volume Report & Daily Profit Focused Screening - newser.com
Why bioAffinity Technologies Inc. stock is in analyst buy zoneWall Street Watch & Low Drawdown Trading Strategies - newser.com
What recovery options are there for bioAffinity Technologies Inc.Trade Analysis Report & Growth Oriented Trade Recommendations - newser.com
Using data filters to optimize entry into bioAffinity Technologies Inc. Equity WarrantJuly 2025 PreEarnings & Fast Gaining Stock Reports - newser.com
Is it time to cut losses on bioAffinity Technologies Inc.Insider Selling & Accurate Buy Signal Alerts - newser.com
Will bioAffinity Technologies Inc. stock see insider buying2025 Market Sentiment & Free Community Supported Trade Ideas - newser.com
Will bioAffinity Technologies Inc. stock maintain momentum in 2025Weekly Trend Report & Low Drawdown Investment Strategies - newser.com
Intraday pattern recognizer results for bioAffinity Technologies Inc. Equity WarrantJuly 2025 Breakouts & AI Driven Stock Price Forecasts - newser.com
Is bioAffinity Technologies Inc. building a consolidation baseQuarterly Portfolio Report & Real-Time Buy Zone Alerts - newser.com
Is bioAffinity Technologies Inc. Equity Warrant stock attractive for retirement portfoliosJuly 2025 Highlights & AI Based Buy/Sell Signal Reports - newser.com
Key resistance and support levels for bioAffinity Technologies Inc. Equity WarrantTake Profit & Fast Entry High Yield Tips - newser.com
Analyzing bioAffinity Technologies Inc. with multi timeframe chartsQuarterly Portfolio Review & Fast Gaining Stock Reports - newser.com
Biotech Stocks To Follow TodayOctober 8th - MarketBeat
How to track smart money flows in bioAffinity Technologies Inc. Equity WarrantVolume Spike & Reliable Entry Point Alerts - newser.com
Visual trend scoring systems applied to bioAffinity Technologies Inc. Equity WarrantJuly 2025 Volume & Trade Opportunity Analysis - newser.com
Developing predictive dashboards with bioAffinity Technologies Inc. data2025 Analyst Calls & Weekly High Momentum Picks - newser.com
WallachBeth Capital Announces The Closing of bioAffinity Technologies $1.8M Registered Direct Financing of Common Stock Priced At-The-Market Under Nasdaq Rules - The Malaysian Reserve
bioAffinity Technologies Announces $1.8M Direct Offering - MSN
bioAffinity Technologies, Inc. Announces Closing of $1.8 Million Registered Direct Financing of Comm - PharmiWeb.com
$1.8M Registered Direct Offering: bioAffinity Closes 720K Shares to Fund CyPath Lung Sales - Stock Titan
bioAffinity Technologies closes $1.8 million registered direct offering - Investing.com India
BioAffinity Technologies Closes $1.8 Million Registered Direct Offering - MarketScreener
bioAffinity Technologies, Inc. Announces Closing of $1.8 Million Registered Direct Financing of Common Stock Priced At-The-Market Under Nasdaq Rules - Business Wire
What analysts say about bioAffinity Technologies Inc stockLong-Term Growth Stocks & Affordable Portfolio Growth - earlytimes.in
Exit strategy if you’re trapped in bioAffinity Technologies Inc.Gap Up & Low Risk Entry Point Guides - newser.com
Does bioAffinity Technologies Inc. Equity Warrant fit your quant trading modelWeekly Trend Recap & Stock Portfolio Risk Control - newser.com
How to build a dashboard for bioAffinity Technologies Inc. stockTrade Risk Report & Long-Term Safe Return Strategies - newser.com
Signal strength of bioAffinity Technologies Inc. stock in tech scannersWeekly Trend Summary & AI Enhanced Market Trend Forecasts - newser.com
Why bioAffinity Technologies Inc. stock appeals to analystsQuarterly Profit Report & Daily Growth Stock Tips - newser.com
Finanzdaten der Bioaffinity Technologies Inc-Aktie (BIAF)
Umsatz
Nettogewinn
Free Cashflow
ENV
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):